Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination? | Clinical and Molecular Hepatology;: 439-442, 2016. | WPRIM

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?

Byung-Cheol SONG.

Clinical and Molecular Hepatology ; : 439-442, 2016.

Article in English | WPRIM (Western Pacific) | ID: wpr-215523

Responsible library: WPRO

ABSTRACT

ABSTRACT

No abstract available.

Chronic hepatitis B; Adefovir; Tenofovir; Lamivudine resistance; Suboptimal response

Search on Google

Full text: Available Database: WPRIM (Western Pacific) Language: English Journal: Clinical and Molecular Hepatology Year: 2016 Document type: Article

Search on Google

Full text: Available Database: WPRIM (Western Pacific) Language: English Journal: Clinical and Molecular Hepatology Year: 2016 Document type: Article